Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ADAM12 Polyclonal Antibody
Goat Polyclonal Antibody
Supplier: Invitrogen™ PA518314
Description
This antibody is tested in Peptide ELISA: antibody detection limit dilution 64,000.
ADAM12 is a member of the ADAM (a disintegrin and metalloprotease-like domain) family. Two forms of ADAM12 have been described: ADAM12S and ADAM12L (short and long forms). The short form is a soluble form lacking the transmembrane and cytoplasmic domains. The short form of ADAM12 was reported to provoke myogenesis, and the lack of cytoplasmic domain suggests different regulation pathways (although both forms can be expressed in the same tissue).
Specifications
ADAM12 | |
Polyclonal | |
Unconjugated | |
ADAM12 | |
a disintegrin and metallopeptidase domain 12 (meltrin alpha); a disintegrin and metalloprotease domain 12; a disintegrin and metalloproteinase; a disintegrin and metalloproteinase domain 12 (meltrin alpha); ADAM; ADAM 12; ADAM metallopeptidase domain 12; Adam12; ADAM12-OT1; ADAMs; CAR10; Disintegrin and metalloproteinase domain-containing protein 12; MCMP; MCMPMltna; meltrin alpha; meltrin-alpha; metalloendopeptidases; metalloprotease-disintegrin 12 transmembrane; mKIAA4001; MLTN; Mltna; PRO545; RP11-295J3.5; UNQ346; UNQ346/PRO545 | |
Goat | |
Ammonium sulfate precipitation | |
RUO | |
8038 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Flow Cytometry, Immunohistochemistry (Paraffin), Immunocytochemistry | |
0.5 mg/mL | |
TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
O43184 | |
ADAM12 | |
Synthetic peptide sequence (AARPLPVSPARALC) corresponding to the N-terminus amino acids of ADAM12 (aa 2-14). | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction